[ad_1] The disappointing results come weeks after a similar treatment developed by two competitors delivered promising data, infusing fresh hope into a field that has been marked by a string of failures. [ad_2] Source link Source link
Read MoreTag: Neurodegenerative Disease Drugs
[ad_1] The veteran pharmaceutical executive takes charge of after the failed launch of Biogen’s once-promising Alzheimer’s disease drug Aduhelm. [ad_2] Source link Source link
Read More